<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two patients with a <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> were evaluated by using both 99mTc-ethyl <z:chebi fb="0" ids="32457">cysteinate</z:chebi> dimer (<z:mp ids='MP_0010412'>ECD</z:mp>, or Bicisate) and 99mTc-hexamethylpropyleneamine <z:chebi fb="0" ids="25750">oxime</z:chebi> (HMPAO) single-<z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomography (SPECT) </plain></SENT>
<SENT sid="1" pm="."><plain>In one patient, 99mTc-<z:mp ids='MP_0010412'>ECD</z:mp> SPECT images revealed <z:mp ids='MP_0001402'>hypoactivity</z:mp> in a reflow hyperemic area where an <z:mpath ids='MPATH_124'>infarct</z:mpath> was seen later on CT scans </plain></SENT>
<SENT sid="2" pm="."><plain>In another patient, a reperfused area showed <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> on 99mTc-<z:mp ids='MP_0010412'>ECD</z:mp> SPECT without any abnormality on follow-up CT </plain></SENT>
<SENT sid="3" pm="."><plain>99mTc-<z:mp ids='MP_0010412'>ECD</z:mp> represents a potential agent with which to evaluate cerebral tissue viability in early reperfusion after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>